Wheeler Bio is a niche biopharmaceutical Contract Development and Manufacturing Organisation (CDMO) that aims to revolutionise the industry by partnering with biologics drug innovators, discovery CROs, and other CDMOs. Founded on the principle of shared success and lasting collaborations, Wheeler Bio addresses the common momentum drop that occurs between the discovery and development stages of drug manufacturing. This drop poses significant technical, financial, and regulatory challenges for emerging biopharma companies. By democratizing manufacturing platforms, Wheeler Bio seeks to mitigate these lifecycle challenges, providing a more streamlined path for drug development.

Services include:
- Biologics
- Regulatory Services
- Protein and Peptide
- Analytical Services
- Mammalian Cell Line and Process Development
- GLP Tox Material Supply
- Efficient cGMP Clinical Supply

Wheeler Bio stands at the forefront of the biopharmaceutical industry, offering innovative solutions that effectively tackle the challenges faced by emerging companies. For more information, please visit wheelerbio.com.